Inventor profile of:

Ian Cottingham

City:

St. Prex

Country:

Switzerland

Published Applications:

15

Last publication date:

2022-10-27

Top Assignees for applications by Ian Cottingham

The entities that hold a legal rights for patent applications filed by inventor Cottingham Ian:

Recent patent applications by Cottingham Ian

Ian Cottingham from St. Prex, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-10-27
US20220340634A1
Chemistry; metallurgy

Pharmaceutical preparation comprising recombinant HCG

#2 | 2022-09-01
US20220275056A1
Chemistry; metallurgy

SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR COMPOSITIONS

#3 | 2022-05-05
US20220135652A1
Chemistry; metallurgy

ADMINISTRATION OF A SELECTIVE IL-6-TRANS-SIGNALLING INHIBITOR

#4 | 2021-10-28
US20210332099A1
Chemistry; metallurgy

Pharmaceutical preparation

#5 | 2020-08-06
US20200247863A1
Chemistry; metallurgy

Pharmaceutical preparation comprising recombinant hCG

#6 | 2020-04-23
US20200123226A1
Chemistry; metallurgy

Selective IL-6-trans-signalling inhibitor compositions

#7 | 2018-10-04
US20180282396A1
Chemistry; metallurgy

Selective IL-6-trans-signalling inhibitor compositions

#8 | 2018-03-22
US20180079794A1
Chemistry; metallurgy

Pharmaceutical preparation

#9 | 2017-11-09
US20170320932A1
Chemistry; metallurgy

Methods for treatment of inflammatory disease or IL-6-mediated condition with gp130 protein

#10 | 2016-12-01
US20160347811A1
Chemistry; metallurgy

Pharmaceutical preparation

#11 | 2015-03-05
US20150065695A1
Chemistry; metallurgy

Recombinant FSH including alpha 2,3- and alpha 2,6-sialylation

#12 | 2014-09-04
US20140249082A1
Chemistry; metallurgy

Pharmaceutical preparation comprising recombinant HcG

#13 | 2014-03-27
US20140088010A1
Human necessities

Pharmaceutical preparation

#14 | 2013-01-24
US20130023476A1
Chemistry; metallurgy

Pharmaceutical preparation comprising recombinant hCG

#15 | 2011-05-05
US20110105398A1
Chemistry; metallurgy

Recombinant FSH including alpha 2,3- and alpha 2,6-sailylation

InventorID:

54534 ⎘